Genetic Influence on Statin Pharmacodynamics
NCT01569854 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-09-27
Summary
The study intends to investigate whether genetics influence how individuals respond to statins (clinical outcomes and changes in carotid intimal media thickness)
Conditions
Sponsors & Collaborators
-
National Institute of General Medical Sciences (NIGMS)
collaborator NIH -
Ohio State University
lead OTHER
Principal Investigators
-
Joseph P Kitzmiller, MD PhD · Ohio State University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2016-03-31
- Completion
- 2022-03-31
Countries
- United States
Study Locations
More Related Trials
-
Genetically Guided Statin Therapy
NCT01894230 ·Status: COMPLETED ·Phase: NA
-
Fenofibrate and Pharmacogenetic Impact in Dyslipidemia
NCT00613613 ·Status: COMPLETED
-
Effect of a Fibrate and a Statin on Endothelial Dysfunction
NCT00491400 ·Status: TERMINATED ·Phase: NA
-
The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study
NCT01053065 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
NCT05889156 ·Status: COMPLETED ·Phase: PHASE2
-
Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes
NCT01265836 ·Status: WITHDRAWN
-
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy
NCT02571257 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)
NCT00726856 ·Status: COMPLETED
-
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
NCT00973986 ·Status: COMPLETED ·Phase: PHASE1
-
Statin Therapy Results in the Real World Practice in the Czech Republic
NCT01055977 ·Status: COMPLETED
-
Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
NCT02072161 ·Status: COMPLETED ·Phase: PHASE2
-
Ezetimibe in Patients Hypo-responsive to Statins
NCT00965055 ·Status: TERMINATED ·Phase: PHASE3
-
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD
NCT00159835 ·Status: COMPLETED ·Phase: PHASE4
-
High Potency Statins and the Risk of Diabetes
NCT02518503 ·Status: COMPLETED
-
Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
NCT02587416 ·Status: COMPLETED ·Phase: PHASE1
-
A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
NCT02634151 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants
NCT01689623 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
NCT06699355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
NCT01779453 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2484595 in Patients With High LDL-C or Low HDL-C
NCT01105975 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
NCT00361283 ·Status: COMPLETED ·Phase: PHASE4
-
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
NCT00145431 ·Status: TERMINATED ·Phase: PHASE3
-
Cholesterol and Pharmacogenetic Study
NCT00451828 ·Status: COMPLETED ·Phase: PHASE4
-
Studies to Gain Insight How the Drugs PCSK9-inhibitors and Statins Affect Cholesterol and Bile Acid Metabolism
NCT06140095 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
NCT05483010 ·Status: RECRUITING ·Phase: PHASE2